UNDA 226 (Seroyal USA)


Welcome to the PulseAid listing for the UNDA 226 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Urtica dioica, Berberis vulgaris, Boldo, Juniperus communis, Aloe socotrina, Chelidonium majus
SUBSTANCE NAME: PEUMUS BOLDUS LEAF; URTICA DIOICA; BERBERIS VULGARIS ROOT BARK; JUNIPER BERRY; ALOE; CHELIDONIUM MAJUS
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-06-02
END MARKETING DATE: 0000-00-00


UNDA 226 HUMAN OTC DRUG Details:

Item DescriptionUNDA 226 from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 6; 6; 6; 6([hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL)
START MARKETING DATE: 2015-06-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-1158_5a9707c1-4e86-c4c6-e053-2a91aa0a6ef6
PRODUCT NDC: 62106-1158
APPLICATION NUMBER:

Other PEUMUS BOLDUS LEAF; URTICA DIOICA; BERBERIS VULGARIS ROOT BARK; JUNIPER BERRY; ALOE; CHELIDONIUM MAJUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USAUNDA 226